Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,669,344
-$28,291 QoQ
Shares Held
6,573
-5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2,503
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProVise Management Group, LLC holds $49,564,821 across 10 Drug Manufacturers - General names. JNJ ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
134,100 | $21,016,152 | |
| 2 | GSK |
GSK plc
|
123,527 | $6,475,285 | |
| 3 | AMGN |
Amgen Inc
|
16,496 | $5,973,531 | |
| 4 | SNY |
Sanofi
|
120,829 | $5,154,565 | |
| 5 | PFE |
Pfizer Inc
|
145,537 | $3,504,530 | |
| 6 | ABBV |
AbbVie Inc.
|
10,735 | $2,701,355 | |
| 7 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
6,573 | $1,669,344 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,669,344 | 6,573 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,697,635 | 6,945 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,911,390 | 9,236 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,824,161 | 9,838 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,510,086 | 9,886 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,710,307 | 10,313 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,583,444 | 10,949 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,005,654 | 12,376 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,971,406 | 13,488 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,243,450 | 14,182 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,528,843 | 16,134 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,713,858 | 23,845 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,951,177 | 41,996 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $5,910,615 | 38,133 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,565,197 | 37,165 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,305,606 | 32,478 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $9,182,947 | 51,732 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,044,674 | 28,464 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $4,429,686 | 25,894 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $4,392,154 | 27,196 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $4,196,422 | 25,473 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,387,323 | 26,695 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $4,260,119 | 27,069 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $3,907,653 | 26,247 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $3,560,470 | 25,318 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,256,220 | 24,832 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||